A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy
Crossref DOI link: https://doi.org/10.1002/sim.5477
Published Online: 2012-07-16
Published Print: 2012-12-20
Update policy: https://doi.org/10.1002/crossmark_policy
Zhong, Wei
Koopmeiners, Joseph S.
Carlin, Bradley P.
Funding for this research was provided by:
NCI (R01-CA095955)
Version of Record valid from 2012-07-16
Text and Data Mining valid from 2012-07-16